JPRN-UMIN000000541已完成未知
The study on the efficacy and safety of pharmacokinetics of mycophenolate mofetil for pediatric renal transplantation - Mycophenolate mofetil for pediatric renal transplantation
Japanese Study group of Pediatric Renal Transplantation0 个研究点目标入组 50 人开始时间: 2007年1月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The acute rejection after renal transplantation. 2. Use ofimmunosuppressant which works the same way as MMF does. 3. Prior exposure to live vaccine within one month before the treatment of MMF 4. Active peptic ulcer disease 5. Severe liver dysfunction 6. Leucopenia at study entry 7. Active systemic infection 8. Malignancy 9. Hemorrhagic diathesis 10. Refractory diarrhea 11. Medical history of severe allergy or drug hypersensitivity 12. ABO-incompatible kidney allograft 13. Anti-donor antibody positive patients 14. Pregnancy 15. Judged inappropriate for this study by the physicians
研究者
相似试验
招募中
不适用
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of sunitinibrenal cell carcinomaJPRN-UMIN000015553Department of Pharmacy, Gifu University Hospital50
已完成
不适用
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of afatinibadenocarcinoma of the lungJPRN-UMIN000014237aboratoly of Pharmacy Practice and Social Science, Gifu Pharmaceutical University43
已完成
不适用
A study to assess the efficacy, safety, pharmacokinetics, and related polymorphism of medicines for pulmonary arterial hypertension in pediatric patientsPulmonary arterial hypertensionJPRN-UMIN000010355Department of clinical pharmacology and genetics, school of pharmaceutical science, university of Shizuoka graduate school100
未知
不适用
A-L03-L088 Other specified local infections of skin and subcutaneous tissue-L02Other specified local infections of skin and subcutaneous tissueL02L03L088PER-006-13Cubist Pharmaceuticals, Inc,
进行中（未招募）
不适用
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure InfectionsEUCTR2015-002778-19-Outside-EU/EEACubist Pharmaceuticals, Inc.389